Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T15:07:20.341Z Has data issue: false hasContentIssue false

Perspectives of patients, close relatives, nurses, and physicians on end-of-life medication management

Published online by Cambridge University Press:  14 August 2017

Marianne K. Dees*
Affiliation:
Radboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
Eric C.T. Geijteman
Affiliation:
Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Wim J.M. Dekkers
Affiliation:
Radboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
Bregje A.A. Huisman
Affiliation:
Department of Anesthesiology, VU University Medical Center, Amsterdam, The Netherlands
Roberto S.G.M. Perez
Affiliation:
Department of Anesthesiology, VU University Medical Center, Amsterdam, The Netherlands EMGO Institute for Health and Care Research, Amsterdam, The Netherlands
Lia van Zuylen
Affiliation:
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Agnes van der Heide
Affiliation:
Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
Evert van Leeuwen
Affiliation:
Radboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands
*
Address correspondence and reprint requests to: Marianne K. Dees, Radboud Institute for Health Sciences, IQ Healthcare, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. E-mail: marianne.dees@radboudumc.nl.

Abstract

Objective:

Our aim was to gain insight into the perspectives of patients, close relatives, nurses, and physicians on medication management for patients with a life expectancy of less than 3 months.

Method:

We conducted an empirical multicenter study with a qualitative approach, including in-depth interviews with patients, relatives, nurses, specialists, and general practitioners (GPs). We used the constant comparative method and ATLAS.ti (v. 7.1) software for our analysis.

Results:

Saturation occurred after 18 patient cases (76 interviews). Some 5 themes covering 18 categories were identified: (1) priorities in end-of-life care, such as symptom management and maintaining hope; (2) appropriate medication use, with attention to unnecessary medication and deprescription barriers; (3) roles in decision making, including physicians in the lead, relatives' advocacy, and pharmacists as suppliers; (4) organization and communication (e.g., transparency of tasks and end-of-life conversations); and (5) prerequisites about professional competence, accessibility and quality of medical records, and financial awareness. Patients, relatives, nurses, specialists, and GPs varied in their opinions about these themes.

Significance of Results:

This study adds to our in-depth understanding of the complex practice of end-of-life medication management. It provides knowledge about the diversity of the perspectives of patients, close relatives, nurses, and physicians regarding beliefs, attitudes, knowledge, skills, behavior, work setting, the health system, and cultural factors related to the matter. Our results might help to draw an interdisciplinary end-of-life medication management guide aimed at stimulating a multidisciplinary and patient-centered pharmacotherapeutic care approach.

Type
Original Article
Copyright
Copyright © Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Alldred, D.P. (2014). Deprescribing: A brave new word? International Journal of Pharmacy Practice, 22(1), 23.Google Scholar
Anderson, K., Stowasser, D., Freeman, C., et al. (2014). Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: A systematic review and thematic synthesis. BMJ Open, 4(12), e006544. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265124/.Google Scholar
Bayliss, E.A., Bronsert, M.R., Reifler, L.M., et al. (2013). Statin prescribing patterns in a cohort of cancer patients with poor prognosis. Journal of Palliative Medicine, 16(4), 412418.Google Scholar
Bélanger, E., Rodríguez, C. & Groleau, D. (2011). Shared decision-making in palliative care: A systematic mixed studies review using narrative synthesis. Palliative Medicine, 25(3), 242261.Google Scholar
Bernacki, R.E. & Block, S.D. (2014). Communication about serious illness care goals: A review and synthesis of best practices. JAMA Internal Medicine, 174(12), 19942003.Google Scholar
Blenkinsopp, A., Bond, C. & Raynor, D.K. (2012). Medication reviews. British Journal Clinical of Pharmacology, 74(4), 573580.Google Scholar
Bluml, B.M. (2005). Definition of medication therapy management: Development of profession wide consensus. Journal of the American Pharmacists Association, 45(5), 566572.Google Scholar
Corbin, J. & Strauss, A. (1990). Grounded theory research: Procedures, canons, and evaluative criteria. Qualitative Sociology, 13(1), 321. Available from http://med-fom-familymed-research.sites.olt.ubc.ca/files/2012/03/W10-Corbin-and-Strauss-grounded-theory.pdf.Google Scholar
Fede, A., Miranda, M., Antonangelo, D., et al. (2011). Use of unnecessary medications by patients with advanced cancer: Cross-sectional survey. Supportive Care in Cancer, 19(9), 13131318.Google Scholar
Hancock, K., Clayton, J.M., Parker, S.M., et al. (2007). Truth-telling in discussing prognosis in advanced life-limiting illnesses: A systematic review. Palliative Medicine, 21(6), 507517.Google Scholar
Holmes, H.M., Haley, D.C., Alexander, D.G., et al. (2006). Reconsidering medication appropriateness for patients late in life. Archives of Internal Medicine, 166(6), 605609.Google Scholar
Kendall, M., Murray, S., Carduff, E., et al. (2009). Use of multiperspective qualitative interviews to understand patients' and carers' beliefs, experiences, and needs. BMJ (Clinical Research Ed.), 339, b4122. Available from http://www.bmj.com/content/339/bmj.b4122.Google Scholar
Koh, N.Y. & Koo, W.H. (2002). Polypharmacy in palliative care: Can it be reduced? Singapore Medical Journal, 43(6), 279283.Google Scholar
Kylmä, J., Duggleby, W., Cooper, D., et al. (2009). Hope in palliative care: An integrative review. Palliative & Supportive Care, 7(3), 365377.Google Scholar
Lee, J.K., Slack, M.K., Martin, J., et al. (2013). Geriatric patient care by U.S. pharmacists in healthcare teams: Systematic review and meta-analyses. Journal of the American Geriatrics Society, 61(7), 11191127.Google Scholar
Maddison, A.R., Fisher, J. & Johnston, G. (2011). Preventive medication use among persons with limited life expectancy. Progress in Palliative Care, 19(1), 1521.Google Scholar
Murray, S.A., Boyd, K., Kendall, M., et al. (2002). Dying of lung cancer or cardiac failure: Prospective qualitative interview study of patients and their carers in the community. BMJ (Clinical Research Ed.), 325(7370), 929. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130056/.Google Scholar
Nauck, F., Ostgathe, C., Klachik, E., et al. (2004). Drugs in palliative care: Results from a representative survey in Germany. Palliative Medicine, 18(2), 100107.Google Scholar
Nordennen, R.T., Lavrijsen, van, J.C., Vissers, K.C., et al. (2014). Decision making about change of medication for comorbid disease at the end of life: An integrative review. Drugs & Aging, 31(7), 501512.Google Scholar
Reeve, E., Wiese, M.D., Hendrix, I., et al. (2013 a). People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. Journal of the American Geriatrics Society, 61(9), 15081514.Google Scholar
Reeve, E., To, J., Hendrix, I., et al. (2013 b). Patient barriers to and enablers of deprescribing: A systematic review. Drugs & Aging, 30(10), 793807.Google Scholar
Reeve, E., Shakib, S., Hendrix, I., et al. (2013 c). Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. International Journal of Clinical Pharmacy, 35(1), 5156.Google Scholar
Ritchie, J. & Lewis, J. (2007). Qualitative Research Practice: A Guide for Social Science Students and Researchers. London: Saga Publications.Google Scholar
Sand, A.M., Harris, J. & Rosland, J.H. (2009). Living with advanced cancer and short life expectancy: Patients' experiences with managing medication. Journal of Palliative Care, 25(2), 8591.Google Scholar
Shah, N.T. (2013). A role for physicians: An observation on cost containment. American Journal of Preventive Medicine, 44(1, Suppl. 1), S19S21.Google Scholar
Tjia, J., Cutrona, S.L., Peterson, D., et al. (2014). Statin discontinuation in nursing home residents with advanced dementia. Journal of the American Geriatrics Society, 62(11), 20952101.Google Scholar
Todd, H., Nazar, H., Pearson, I., et al. (2014). Inappropriate prescribing in patients accessing specialist palliative day care services. International Journal of Clinical Pharmacy, 36(3), 535543.Google Scholar
Todd, A., Husband, A., Andrew, I., et al. (2015). Inappropriate prescribing of preventative medication in patients with life-limiting illness: A systematic review. BMJ Supportive & Palliative Care, 7(2), 113121.Google Scholar
Turner, J.P., Edwards, S., Stanners, M., et al. (2016). What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open, 6(3), e009781. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800122/.Google Scholar
Witkamp, F.E., van Zuylen, L., Borsboom, G., et al. (2015). Dying in the hospital: What happens and what matters, according to bereaved relatives. Journal of Pain and Symptom Management, 49(2), 203213.Google Scholar